Androgenetic alopecia and Appetite - decreased

Summary:

Appetite - decreased is found among people with Androgenetic alopecia, especially for people who are male, 50-59 old.

The study analyzes which people have Appetite - decreased with Androgenetic alopecia. It is created by eHealthMe based on reports of 39 people who have Androgenetic alopecia from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Androgenetic alopecia?

Androgenetic alopecia (common form of hair loss) is found to be associated with 34 drugs and 138 conditions by eHealthMe. Check the latest studies of Androgenetic alopecia.

What is Appetite - decreased?

Appetite - decreased (decreased appetite occurs when you have a reduced desire to eat) is found to be associated with 3,526 drugs and 4,592 conditions by eHealthMe. Check the latest studies of Appetite - decreased.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 20, 2026

39 people who have Androgenetic Alopecia and Appetite - Decreased are studied.

Would you have Appetite - decreased when you have Androgenetic alopecia?

Gender of people who have Androgenetic Alopecia and experienced Appetite - Decreased *:

female: 15.38 %
male: 84.62 %

Age of people who have Androgenetic Alopecia and experienced Appetite - Decreased *:

Common co-existing conditions for these people *:

Hair Loss: 15 people, 38.46%
Attention Deficit Hyperactivity Disorder (a chronic condition including attention difficulty, hyperactivity, and impulsiveness): 5 people, 12.82%
Stress And Anxiety: 3 people, 7.69%
Premature Ejaculation: 2 people, 5.13%
Sleep Disorder: 1 person, 2.56%
Prostatitis (inflammation of the prostate gland): 1 person, 2.56%
Oral Herpes (viral infection of mouth): 1 person, 2.56%
Major Depression (a mood state that goes well beyond temporarily feeling sad or blue. it is a serious medical illness that affects one's thoughts, feelings): 1 person, 2.56%
Insomnia (sleeplessness): 1 person, 2.56%
Hypogonadism (reduction or absence of hormone secretion or other physiological activity of the gonads (testes or ovaries)): 1 person, 2.56%

Common drugs taken by these people *:

Propecia: 32 people, 82.05%
Ritalin: 5 people, 12.82%
Cialis: 3 people, 7.69%
Fenofibrate: 2 people, 5.13%
Finasteride: 2 people, 5.13%
Zoloft: 2 people, 5.13%
Metformin Hydrochloride: 2 people, 5.13%
Mestinon: 2 people, 5.13%
Zytiga: 1 person, 2.56%
Lamictal: 1 person, 2.56%

Common symptoms for these people *:

Cognitive Disorder (mental health disorders affects learning, memory, perception, and problem solving): 30 people, 76.92%
Depression: 30 people, 76.92%
Erection Problems: 29 people, 74.36%
Fatigue (feeling of tiredness): 28 people, 71.79%
Stress And Anxiety: 28 people, 71.79%
Insomnia (sleeplessness): 27 people, 69.23%
Libido Decreased (loss of interest in sex): 22 people, 56.41%
Headache (pain in head): 19 people, 48.72%
Weight Decreased: 18 people, 46.15%
Memory Loss: 17 people, 43.59%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Appetite - decreased?

- Check whether Appetite - decreased is associated with a drug or a condition

Related studies:

How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Appetite - decreased and Androgenetic alopecia, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.